Eligini, S.
61  Ergebnisse:
Personensuche X
?
1

PB0124 Treatment with PCSK9 Inhibitors in Patients with Fam..:

Calcaterra, I. ; Di Minno, A. ; Orsini, R....
Research and Practice in Thrombosis and Haemostasis.  7 (2023)  - p. 100925 , 2023
 
?
 
?
 
?
6

P505An untargeted metabolomics approach reveals unusual pat..:

Porro, B ; Turnu, L ; Manega, C M...
Cardiovascular Research.  114 (2018)  suppl_1 - p. S123-S123 , 2018
 
?
9

Inhibition of transglutaminase 2 reduces efferocytosis in h..:

Eligini, S. ; Fiorelli, S. ; Tremoli, E..
Nutrition, Metabolism and Cardiovascular Diseases.  26 (2016)  10 - p. 922-930 , 2016
 
?
 
?
12

P703NO synthetic pathway and oxidative stress in microvascu..:

Porro, B ; Eligini, S ; Veglia, F...
Cardiovascular Research.  103 (2014)  suppl 1 - p. S128.5-S128 , 2014
 
?
 
?
14

Mitochondrial reactive oxygen species: a common pathway for..:

BANFI, C. ; BRIOSCHI, M. ; BARBIERI, S. S....
Journal of Thrombosis and Haemostasis.  7 (2009)  1 - p. 206-216 , 2009
 
?
15

Fatty acid composition of plasma, blood cells and whole blo..:

Risé, P. ; Eligini, S. ; Ghezzi, S...
Prostaglandins, Leukotrienes and Essential Fatty Acids.  76 (2007)  6 - p. 363-369 , 2007
 
1-15